Berlin: Scientists have identified highly effective antibodies against the novel coronavirus, which they say can lead to the development of a passive vaccination for COVID-19.Unlike in active vaccination, passive vaccination involves the administration of ready-made antibodies, which are degraded after some time.However, the effect of a passive vaccination is almost immediate, whereas with an active vaccination it has to build up first, the researchers said.The research, published in the journal Cell, also shows that some SARS-CoV-2 antibodies bind to tissue samples from various organs, which could potentially trigger undesired side effects.The scientists at the German Center for Neurodegenerative Diseases (DZNE) and Charite -.